Actively Recruiting
CADASIL Registry Study
Led by Bin Cai · Updated on 2023-09-28
1000
Participants Needed
1
Research Sites
1513 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to determine the clinical spectrum and natural progression of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and related disorders in a prospective multicenter study, to assess the clinical, genetic and epigenetic features of patients with CADASIL , to optimize clinical management.
CONDITIONS
Official Title
CADASIL Registry Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Age over 18 years
- Clinical diagnosis of CADASIL confirmed by genetic test or skin biopsy
- Asymptomatic NOTCH3 mutation carriers
- Relatives of CADASIL patients or carriers
- Unrelated healthy controls
You will not qualify if you...
- Unable to cooperate with inspectors
- Serious systemic illness such as heart, liver, or kidney disease, or major mental illness
- Contraindications for imaging examination
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Neurology , First Affiliated Hospital Fujian Medical University
Fuzhou, Fujian, China, 350004
Actively Recruiting
Research Team
L
Lin Yi, PhD
CONTACT
C
Cai Bin, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here